# Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone

> **NCT00925457** · — · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 1608 (actual)

## Conditions studied

- Arrhythmias, Cardiac

## Interventions

- **OTHER:** No Intervention
- **DRUG:** Current Domperidone
- **DRUG:** Current proton pump inhibitor (PPI)

## Key facts

- **NCT ID:** NCT00925457
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 1608 (ACTUAL)
- **Last updated:** 2016-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00925457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00925457, "Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00925457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*